MedTrace Logo

Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects

NCT03060746 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 277

Last updated 2021-12-30

No results posted yet for this study

Summary

The primary objective is to obtain stool samples from pre-therapy subjects already undergoing evaluation for an H. pylori infection by upper esophagogastroduodenoscopy (EGD) and gastric biopsy.

Conditions

Interventions

OTHER

Newly Diagnosed

Gastric biopsy tested by composite reference method (CRM) (histology, urease, culture) and stool sample

Sponsors & Collaborators

  • ICON Clinical Research

    collaborator INDUSTRY

  • DiaSorin Inc.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-14
Primary Completion
2018-05-03
Completion
2018-05-03

Countries

  • United States
  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03060746 on ClinicalTrials.gov